Wednesday - August 27, 2025
University of Glasgow: Revealing the Impact of Tirzepatide Treatment on Muscle Composition in Type 2 Diabetes
May 01, 2025
GLASGOW, Scotland, May 1 -- The University of Glasgow issued the following news:

* * *

Revealing the impact of tirzepatide treatment on muscle composition in type 2 diabetes

A recent analysis of the SURPASS-3 trial unravels the impact of treatment with the drug tirzepatide on muscle volume and fat infiltration in individuals with Type 2 Diabetes.

Published in The Lancet Diabetes & Endocrinology, the study is the result of a research collabo . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products